Drug targets in infections with Ebola and Marburg viruses

Olinger G. Gene, Biggins E. Julia, Melanson R. Vanessa, Wahl Jensen Victoria, Thomas Geisbert, Hensley E. Lisa

Research output: Contribution to journal › Article

13 Citations (Scopus)

Abstract

The development of antiviral drugs for Ebola and Marburg viruses has been slow. To date, beyond supportive care, no effective treatments, prophylactic measures, therapies, or vaccines are approved to treat or prevent filovirus infections. In this review, we examine the current treatments available to administer care for filovirus infection, the potential therapeutic targets that can be used for filovirus drug development, and the various drug targeting techniques used against filoviruses.

Original languageEnglish (US)
Pages (from-to)191-200
Number of pages10
JournalInfectious Disorders - Drug Targets
Volume9
Issue number2
StatePublished - 2009
Externally publishedYes

Fingerprint

Marburgvirus
Ebolavirus
Infection
Pharmaceutical Preparations
Active Immunotherapy
Drug Delivery Systems
Antiviral Agents
Therapeutics

Keywords

  • Drug targets
  • Ebola virus
  • Filoviridae
  • Immunotherapy
  • Marburg virus
  • Pathogenesis
  • Pathology
  • Therapeutics

ASJC Scopus subject areas

  • Molecular Medicine
  • Microbiology (medical)
  • Pharmacology

Cite this

Gene, O. G., Julia, B. E., Vanessa, M. R., Victoria, W. J., Geisbert, T., & Lisa, H. E. (2009). Drug targets in infections with Ebola and Marburg viruses. Infectious Disorders - Drug Targets, 9(2), 191-200.

Drug targets in infections with Ebola and Marburg viruses. / Gene, Olinger G.; Julia, Biggins E.; Vanessa, Melanson R.; Victoria, Wahl Jensen; Geisbert, Thomas; Lisa, Hensley E.

In: Infectious Disorders - Drug Targets, Vol. 9, No. 2, 2009, p. 191-200.

Research output: Contribution to journal › Article

Gene, OG, Julia, BE, Vanessa, MR, Victoria, WJ, Geisbert, T & Lisa, HE 2009, 'Drug targets in infections with Ebola and Marburg viruses', Infectious Disorders - Drug Targets, vol. 9, no. 2, pp. 191-200.
Gene OG, Julia BE, Vanessa MR, Victoria WJ, Geisbert T, Lisa HE. Drug targets in infections with Ebola and Marburg viruses. Infectious Disorders - Drug Targets. 2009;9(2):191-200.
Gene, Olinger G. ; Julia, Biggins E. ; Vanessa, Melanson R. ; Victoria, Wahl Jensen ; Geisbert, Thomas ; Lisa, Hensley E. / Drug targets in infections with Ebola and Marburg viruses. In: Infectious Disorders - Drug Targets. 2009 ; Vol. 9, No. 2. pp. 191-200.
@article{9cf13d382bb74f02abb5296c78f25186,
title = "Drug targets in infections with Ebola and Marburg viruses",
abstract = "The development of antiviral drugs for Ebola and Marburg viruses has been slow. To date, beyond supportive care, no effective treatments, prophylactic measures, therapies, or vaccines are approved to treat or prevent filovirus infections. In this review, we examine the current treatments available to administer care for filovirus infection, the potential therapeutic targets that can be used for filovirus drug development, and the various drug targeting techniques used against filoviruses.",
keywords = "Drug targets, Ebola virus, Filoviridae, Immunotherapy, Marburg virus, Pathogenesis, Pathology, Therapeutics",
author = "Gene, {Olinger G.} and Julia, {Biggins E.} and Vanessa, {Melanson R.} and Victoria, {Wahl Jensen} and Thomas Geisbert and Lisa, {Hensley E.}",
year = "2009",
language = "English (US)",
volume = "9",
pages = "191--200",
journal = "Infectious Disorders - Drug Targets",
issn = "1871-5265",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Drug targets in infections with Ebola and Marburg viruses

AU - Gene, Olinger G.

AU - Julia, Biggins E.

AU - Vanessa, Melanson R.

AU - Victoria, Wahl Jensen

AU - Geisbert, Thomas

AU - Lisa, Hensley E.

PY - 2009

Y1 - 2009

N2 - The development of antiviral drugs for Ebola and Marburg viruses has been slow. To date, beyond supportive care, no effective treatments, prophylactic measures, therapies, or vaccines are approved to treat or prevent filovirus infections. In this review, we examine the current treatments available to administer care for filovirus infection, the potential therapeutic targets that can be used for filovirus drug development, and the various drug targeting techniques used against filoviruses.

AB - The development of antiviral drugs for Ebola and Marburg viruses has been slow. To date, beyond supportive care, no effective treatments, prophylactic measures, therapies, or vaccines are approved to treat or prevent filovirus infections. In this review, we examine the current treatments available to administer care for filovirus infection, the potential therapeutic targets that can be used for filovirus drug development, and the various drug targeting techniques used against filoviruses.

KW - Drug targets

KW - Ebola virus

KW - Filoviridae

KW - Immunotherapy

KW - Marburg virus

KW - Pathogenesis

KW - Pathology

KW - Therapeutics

UR - http://www.scopus.com/inward/record.url?scp=67649203671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649203671&partnerID=8YFLogxK

M3 - Article

C2 - 19275706

AN - SCOPUS:67649203671

VL - 9

SP - 191

EP - 200

JO - Infectious Disorders - Drug Targets

JF - Infectious Disorders - Drug Targets

SN - 1871-5265

IS - 2

ER -

Access to Document